Cumberland Retained Earnings from 2010 to 2025

CPIX Stock

USD 2.53 0.24 8.66%

Cumberland Pharmaceuticals Retained Earnings yearly trend continues to be fairly stable with very little volatility. Retained Earnings are likely to outpace its year average in 2025. Retained Earnings is the cumulative amount of net income that Cumberland Pharmaceuticals retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2006-12-31

Previous Quarter

-20.5 M

Current Value

-22.1 M

Quarterly Volatility

11.3 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Cumberland Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cumberland Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7 M, Interest Expense of 631.1 K or Selling General Administrative of 8.9 M, as well as many indicators such as Price To Sales Ratio of 0.71, Dividend Yield of 0.0 or PTB Ratio of 0.94. Cumberland financial statements analysis is a perfect complement when working with Cumberland Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of Cumberland Pharmaceuticals Correlation against competitors.

For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.

Latest Cumberland Pharmaceuticals' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Cumberland Pharmaceuticals over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Cumberland Pharmaceuticals' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cumberland Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (17.49 M)

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

Cumberland Retained Earnings Regression Statistics

	Arithmetic Mean	2,704,014
	Coefficient Of Variation	520.84
	Mean Deviation	12,418,304
	Median	4,746,154
	Standard Deviation	14,083,711
	Sample Variance	198.4T
	Range	37M
	R-Value	(0.70)
	Mean Square Error	109.6T
	R-Squared	0.48
	Significance	0
	Slope	(2,058,842)
	Total Sum of Squares	2975.3T

Cumberland Retained Earnings History

	2025	-15 M
	2024	-15.7 M
	2023	-17.5 M
	2022	-11.2 M
	2021	-5.6 M
	2020	-2.1 M
	2019	1.2 M

Other Fundumenentals of Cumberland Pharmaceuticals

Retained Earnings Total Equity

Cumberland Pharmaceuticals Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Long Term Debt	Common Stock	Property Plant Equipment	Net Tangible Assets	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.6	0.9	-0.2	0.35	0.31	0.48	0.39	0.71	0.18	0.66	0.4	0.72	0.23	-0.31	0.29	0.1	-0.01	-0.16	-0.04
Total Stockholder Equity	0.6		0.51	-0.83	0.87	-0.43	-0.25	-0.44	0.94	0.33	-0.08	-0.44	0.9	-0.32	0.49	-0.56	0.07	0.54	0.56	0.34
Current Deferred Revenue	0.9	0.51		-0.09	0.13	0.49	0.52	0.48	0.58	0.1	0.59	0.33	0.6	0.23	-0.46	0.25	0.18	-0.33	-0.38	-0.39
Net Debt	-0.2	-0.83	-0.09		-0.86	0.76	0.45	0.78	-0.76	-0.39	0.5	0.66	-0.78	0.53	-0.82	0.75	-0.02	-0.67	-0.81	-0.59
Retained Earnings	0.35	0.87	0.13	-0.86		-0.69	-0.43	-0.69	0.76	0.46	-0.17	-0.56	0.75	-0.45	0.72	-0.66	0.04	0.82	0.85	0.72
Accounts Payable	0.31	-0.43	0.49	0.76	-0.69		0.73	0.94	-0.28	-0.08	0.67	0.76	-0.34	0.57	-0.94	0.79	0.29	-0.77	-0.9	-0.77
Net Receivables	0.48	-0.25	0.52	0.45	-0.43	0.73		0.75	-0.09	0.04	0.69	0.71	0.01	0.54	-0.75	0.67	0.13	-0.61	-0.67	-0.41
Total Liab	0.39	-0.44	0.48	0.78	-0.69	0.94	0.75		-0.25	-0.24	0.75	0.89	-0.3	0.63	-0.97	0.9	0.13	-0.72	-0.92	-0.69
Total Current Assets	0.71	0.94	0.58	-0.76	0.76	-0.28	-0.09	-0.25		0.32	0.02	-0.21	0.89	-0.3	0.36	-0.33	0.12	0.48	0.43	0.28
Short Term Debt	0.18	0.33	0.1	-0.39	0.46	-0.08	0.04	-0.24	0.32		0.02	-0.12	0.24	-0.21	0.22	-0.19	0.82	0.4	0.44	0.36
Intangible Assets	0.66	-0.08	0.59	0.5	-0.17	0.67	0.69	0.75	0.02	0.02		0.76	0.06	0.48	-0.77	0.7	0.1	-0.32	-0.54	-0.21
Long Term Debt	0.4	-0.44	0.33	0.66	-0.56	0.76	0.71	0.89	-0.21	-0.12	0.76		-0.22	0.6	-0.82	0.98	0.08	-0.47	-0.73	-0.34
Common Stock	0.72	0.9	0.6	-0.78	0.75	-0.34	0.01	-0.3	0.89	0.24	0.06	-0.22		-0.2	0.34	-0.34	-0.08	0.36	0.4	0.38
Property Plant Equipment	0.23	-0.32	0.23	0.53	-0.45	0.57	0.54	0.63	-0.3	-0.21	0.48	0.6	-0.2		-0.59	0.61	-0.09	-0.39	-0.61	-0.38
Net Tangible Assets	-0.31	0.49	-0.46	-0.82	0.72	-0.94	-0.75	-0.97	0.36	0.22	-0.77	-0.82	0.34	-0.59		-0.84	-0.14	0.79	0.93	0.7
Long Term Debt Total	0.29	-0.56	0.25	0.75	-0.66	0.79	0.67	0.9	-0.33	-0.19	0.7	0.98	-0.34	0.61	-0.84		0.06	-0.55	-0.78	-0.41
Short Long Term Debt	0.1	0.07	0.18	-0.02	0.04	0.29	0.13	0.13	0.12	0.82	0.1	0.08	-0.08	-0.09	-0.14	0.06		0.02	0.04	-0.13
Net Invested Capital	-0.01	0.54	-0.33	-0.67	0.82	-0.77	-0.61	-0.72	0.48	0.4	-0.32	-0.47	0.36	-0.39	0.79	-0.55	0.02		0.9	0.84
Net Working Capital	-0.16	0.56	-0.38	-0.81	0.85	-0.9	-0.67	-0.92	0.43	0.44	-0.54	-0.73	0.4	-0.61	0.93	-0.78	0.04	0.9		0.83
Capital Stock	-0.04	0.34	-0.39	-0.59	0.72	-0.77	-0.41	-0.69	0.28	0.36	-0.21	-0.34	0.38	-0.38	0.7	-0.41	-0.13	0.84	0.83

Click cells to compare fundamentals

About Cumberland Pharmaceuticals Financial Statements

Cumberland Pharmaceuticals investors use historical fundamental indicators, such as Cumberland Pharmaceuticals' Retained Earnings, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cumberland Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Retained Earnings	-15.7 M	-15 M
Retained Earnings Total Equity	-1.9 M	-1.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
V	Visa Class A
C	Citigroup

Additional Tools for Cumberland Stock Analysis

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC